Biomarin Pharm Company Profile

✉ Email this page to a colleague

BIOMARIN PHARM has three approved drugs.

There are fourteen US patents protecting BIOMARIN PHARM drugs.

There are one hundred and sixty-four patent family members on BIOMARIN PHARM drugs in thirty-one countries and nine supplementary protection certificates in nine countries.

International Patents:	164
US Patents:	14
Tradenames:	2
Ingredients:	2
NDAs:	3
Patent Litigation for Biomarin Pharm:	See patent lawsuits for Biomarin Pharm

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Biomarin Pharm	VOXZOGO	vosoritide	POWDER;SUBCUTANEOUS	214938-003	Nov 19, 2021		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Biomarin Pharm	VOXZOGO	vosoritide	POWDER;SUBCUTANEOUS	214938-002	Nov 19, 2021		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	TABLET;ORAL	022181-001	Dec 13, 2007	AB	RX	Yes	Yes	7,612,073*PED	⤷ Try a Trial			Y	⤷ Try a Trial
Biomarin Pharm	VOXZOGO	vosoritide	POWDER;SUBCUTANEOUS	214938-001	Nov 19, 2021		RX	Yes	Yes	10,646,550	⤷ Try a Trial	Y			⤷ Try a Trial
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	TABLET;ORAL	022181-001	Dec 13, 2007	AB	RX	Yes	Yes	RE43797*PED	⤷ Try a Trial			Y	⤷ Try a Trial
Biomarin Pharm	VOXZOGO	vosoritide	POWDER;SUBCUTANEOUS	214938-001	Nov 19, 2021		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	100 mg	➤ Subscribe	2014-05-30
➤ Subscribe	Powder for Oral Solution	500 mg/packet	➤ Subscribe	2016-12-20
➤ Subscribe	Powder for Oral Solution	100 mg per packet	➤ Subscribe	2015-11-09

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2432489	301162	Netherlands	⤷ Try a Trial	PRODUCT NAME: VOSORITIDE IN IEDERE VORM ZOALS BESCHERMD DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/21/1577 20210901
2432489	2022C/503	Belgium	⤷ Try a Trial	PRODUCT NAME: VOSORITIDE SOUS TOUTES SES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/21/1577 20210901
2432489	122022000008	Germany	⤷ Try a Trial	PRODUCT NAME: VOSORITID IN ALLEN DURCH DAS GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/21/1577 20210826
2432489	2290005-4	Sweden	⤷ Try a Trial	PRODUCT NAME: VOSORITIDE; REG. NO/DATE: EU/1/21/1577 20210921
2432489	LUC00248	Luxembourg	⤷ Try a Trial	PRODUCT NAME: VOSORITIDE SOUS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/21/1577 20210901
2432489	C202230004	Spain	⤷ Try a Trial	PRODUCT NAME: VOSORITIDE; NATIONAL AUTHORISATION NUMBER: EU/1/21/1577; DATE OF AUTHORISATION: 20210826; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1577; DATE OF FIRST AUTHORISATION IN EEA: 20210826
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.